Encouraging Trial Results for Hep C Drug Faldaprevir
Share
Follow Us
The Editors at Hepatitis Central
May 2, 2013
Data from Boehringer Ingelheim’s Phase III trial of faldaprevir claims high success rates for treatment-naïve patients with Hepatitis C genotype 1.
Boehringer Ingelheim reports positive data from hepatitis drug trial
25 April 2013 11:01 in Pharmaceutical Company Product News
Boehringer Ingelheim has reported positive results from STARTVerso 1, a phase III trial evaluating the benefits of the new hepatitis C treatment faldaprevir.
Data from the study showed that the new once-daily protease inhibitor was able to deliver high viral cure rates and early therapy success among treatment-naive patients with genotype 1 hepatitis C infections.
Continue reading this entire article:
http://www.zenopa.com/news/801576832/boehringer-ingelheim-reports-positive-data-from-hepatitis-drug-trial
5 Comments
if a person is in 5 month stage of caner remmision and has a brain aneurysm are they a candidate for hep c treatment ?
is it effective for genotype 4
WHY DOES MY COMPUTER KEEP FREEZING EVERY TIME I CLICK YOUR ATTACHMENTS WHICH ARE IMPORTANT TO ME! I’D LIKE TO FIND SOMETHING POSITIVE FOR MY TYPE 1, WITHOUT COMPROMISING MY ONLINE SECURITY. ANYONE ELSE HAVE THE SAME PROBLEM?????
will they do a study for hep c patients whose first treatment failed?
i am taking this in blind trail study i have hep c Europe type since 1974 i have some cerrose i do not drink or smoke i keep tellind doctor i am on plecbo because i have no side affect at all 4 weaks left to go and thery tell me hep c was all gone befor 8 weaks i am so happy now 13 pills a day lucky 13 for me and iam told people in early stydy trials are still hep free after 2 and 3 years but dont know how its works on other types